Our Past Projects
• MEDICAL Device Study• Infectious diseases (Dengue, Zika, Influenza, COVID-19)• Clinical pharmacology & pharmacogenetics programme• Chronobiology sleep and circadian rhythm studies
Collaboration with Duke UniversitySingHealth IMU, Duke University's Clinical Research Unit (Carolina, USA) and Medanta IMU (India) have signed a memorandum of understanding to facilitate appropriate multi-site studies at the three institutions. Project that has been initiated since its launch include:
• Microarray signatures to aspirin response study• Olfactory Bulb Imaging using MRI machine
Collaboration with IndustrySingHealth IMU has collaborative agreements with most major pharmaceutical companies and CROs, including:
• Covance
• Parexel
• IQVIA
• MSD
• GlaxoSmithKline (GSK)
• Novartis OTM
• PPD
• Servier
• Arcturus Therapeutics
• Pfizer
• Esai
• Takeda/Millennium
• Bayer
• Boehringer Ingelheim
• Sanofi
• Fibrogen
• AstraZeneca
Site Inspections & AuditsSingHealth IMU has been inspected by the Health Sciences Authority of Singapore and audited by major pharmaceutical companies / CROs such as GSK, IQVIA, Celerion and is approved as a full clinical trial site.
